This compound is a bioconjugation reagent featuring a DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) core and a maleimide group. Its design enables site-specific attachment to targeting molecules, making it a tool for constructing targeted imaging agents.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1006711-90-5
(2-chloropyridin-4-yl)methanol
research compound
2-(2-Naphthalenyl)pyrrolidine
research compound
2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzo[d]thiazole
Boronic acid ester building block
2-NP-AHD-13C3
isotope-labeled analytical reference standard
Tri-tert-butyl 2,2',2''-(10-(2-((2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate
DOTA-based bioconjugation building block
2-[4,7-bis(carboxymethyl)-10-[2-[2-(2,5-dioxopyrrol-1-yl)ethylamino]-2-oxoethyl]-1,4,7,10-tetrazacyclododec-1-yl]acetic acid
AUTDIWAXETZSGJ-UHFFFAOYSA-N
C1CN(CCN(CCN(CCN1CC(=O)NCCN2C(=O)C=CC2=O)CC(=O)O)CC(=O)O)CC(=O)O